Chi-Jen Lo

1H Nuclear Magnetic Resonance (NMR)-Based Cerebrospinal Fluid and Plasma Metabolomic Analysis in Type 2 Diabetic Patients and Risk Prediction for Diabetic Microangiopathy

Huan-Tang Lin, Mei‐Ling Cheng, Chi-Jen Lo et al. · Journal of Clinical Medicine · 2019 · 45 citations · Full text

Metabolomic Profiling, Metabolic Syndrome, Diabetic Neuropathy +19

Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy

Shih-Chun Cheng, Kueian Chen, Chih‐Yung Chiu et al. · Metabolomics · 2019 · 43 citations

Biomarker (Medicine), Metabolomic Biomarkers, Endocrine-related Cancer +13

Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease

I‐Wen Wu, Tsung-Hsien Tsai, Chi-Jen Lo et al. · npj Digital Medicine · 2022 · 31 citations · Full text

Artificial Intelligence, Trans-omics Biomarker Signature, Engineering +20

Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study

Kung‐Hao Liang, Mei‐Ling Cheng, Chi-Jen Lo et al. · Scientific Reports · 2020 · 30 citations · Full text

Characteristic of Metabolic Status in Heart Failure and Its Impact in Outcome Perspective

Hsiang-Yu Tang, Chao‐Hung Wang, Hung‐Yao Ho et al. · Metabolites · 2020 · 26 citations · Full text